Diagnos Laboratorium Utama Tbk. vs Indospring Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Indospring Tbk. trades at Rp262 (market cap 1.73T, 1.03M 24h volume). The key difference: Indospring Tbk. is far larger — about 5.6× Diagnos Laboratorium Utama Tbk.'s market cap, and Indospring Tbk. is more actively traded (1.03M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | INDS | |
|---|---|---|
Market Cap | 310.75B | 1.73T |
Volume | 963.6K | 1.03M |
Lot | 9.64K | 10.31K |
Turnover | 217.67M | 271.2M |
Average Price | 225.89 | 263.14 |
Value | 217.67M | 271.2M |
Indicative Equilibrium Price | 226 | 262 |
Indicative Equilibrium Volume | 1K | 1.32K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Indospring started its operations in 1978 producing motor vehicles, railway rolling stocks and industrial machinery. The company has an technical assistance agreement with Mitsubishi Steel Manufacturing Co., And recently the products are also exported.
Read more on INDS →